NHS Grants Palantir Unlimited Patient Data Access

Enhanced Key Takeaways

• •The NHS Federated Data Platform (FDP) contract, awarded to Palantir in late 2023, has faced sustained legal and ethical scrutiny regarding patient opt-out mechanisms and the scope of data processing.
• •Privacy advocates and the British Medical Association (BMA) have consistently raised concerns that the FDP's architecture could facilitate 'function creep,' where data collected for clinical care is repurposed for commercial or secondary research without explicit patient consent.
• •NHS England maintains that the platform is designed to improve operational efficiency and patient outcomes, asserting that strict governance frameworks and data protection impact assessments (DPIAs) are in place to mitigate privacy risks.

Technical Deep Dive

• •The NHS Federated Data Platform (FDP) is built upon Palantir Foundry, an operating system for modern enterprise that integrates disparate data sources into a unified data asset.
• •The platform utilizes a 'data safe haven' architecture, which is intended to provide a secure environment for processing sensitive health data while maintaining audit trails for all user access.
• •Data within the FDP is subject to role-based access control (RBAC) and attribute-based access control (ABAC) to restrict visibility based on the user's specific clinical or administrative role.
• •The NDIT (National Data Infrastructure Team) environment acts as a staging area where raw, identifiable data is ingested before undergoing pseudonymization processes for downstream analytical use.

Future ImplicationsAI analysis grounded in cited sources

Timeline